Literature DB >> 25612218

Ascending control of arousal and motivation: role of nucleus incertus and its peptide neuromodulators in behavioural responses to stress.

S Ma1,2, A L Gundlach1,2,3.   

Abstract

Arousal is a process that involves the activation of ascending neural pathways originating in the rostral pons that project to the forebrain through the midbrain reticular formation to promote the activation of key cortical, thalamic, hypothalamic and limbic centres. Established modulators of arousal include the cholinergic, serotonergic, noradrenergic and dopaminergic networks originating in the pons and midbrain. Recent data indicate that a population of largely GABAergic projection neurones located in the nucleus incertus (NI) are also involved in arousal and motivational processes. The NI has prominent efferent connections with distinct hypothalamic, amygdalar and thalamic nuclei, in addition to dense projections to key brain regions associated with the generation and pacing of hippocampal activity. The NI receives strong inputs from the prefrontal cortex, lateral habenula and the interpeduncular and median raphe nuclei, suggesting it is highly integrated in circuits regulating higher cognitive behaviours (hippocampal theta rhythm) and emotion. Anatomical and functional studies have revealed that the NI is a rich source of multiple peptide neuromodulators, including relaxin-3, and may mediate extra-hypothalamic effects of the stress hormone corticotrophin-releasing factor, as well as other key modulators such as orexins and oxytocin. This review provides an overview of earlier studies and highlights more recent research that implicates this neural network in the integration of arousal and motivated behaviours and has begun to identify the associated mechanisms. Future research that should help to better clarify the connectivity and function of the NI in major experimental species and humans is also discussed.
© 2015 British Society for Neuroendocrinology.

Entities:  

Keywords:  arousal; corticotrophin-releasing factor; motivation; nucleus incertus; orexin; oxytocin; relaxin-3; stress

Mesh:

Substances:

Year:  2015        PMID: 25612218     DOI: 10.1111/jne.12259

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  14 in total

1.  CRF and the nucleus incertus: a node for integration of stress signals.

Authors:  Leigh C Walker; Andrew J Lawrence
Journal:  Nat Rev Neurosci       Date:  2016-11-24       Impact factor: 34.870

Review 2.  Dual-transmitter systems regulating arousal, attention, learning and memory.

Authors:  Sherie Ma; Balázs Hangya; Christopher S Leonard; William Wisden; Andrew L Gundlach
Journal:  Neurosci Biobehav Rev       Date:  2017-07-27       Impact factor: 8.989

Review 3.  Anxiety and Nicotine Dependence: Emerging Role of the Habenulo-Interpeduncular Axis.

Authors:  Susanna Molas; Steven R DeGroot; Rubing Zhao-Shea; Andrew R Tapper
Journal:  Trends Pharmacol Sci       Date:  2016-11-24       Impact factor: 14.819

Review 4.  Distribution, physiology and pharmacology of relaxin-3/RXFP3 systems in brain.

Authors:  Sherie Ma; Craig M Smith; Anna Blasiak; Andrew L Gundlach
Journal:  Br J Pharmacol       Date:  2016-12-04       Impact factor: 8.739

5.  Sensitivity to Chronic Methamphetamine Administration and Withdrawal in Mice with Relaxin-3/RXFP3 Deficiency.

Authors:  Mouna Haidar; Monica Lam; Berenice E Chua; Craig M Smith; Andrew L Gundlach
Journal:  Neurochem Res       Date:  2015-05-29       Impact factor: 3.996

Review 6.  Review of the cytology and connections of the lateral habenula, an avatar of adaptive behaving.

Authors:  Daniel S Zahm; David H Root
Journal:  Pharmacol Biochem Behav       Date:  2017-06-21       Impact factor: 3.533

7.  Central amygdala relaxin-3/relaxin family peptide receptor 3 signalling modulates alcohol seeking in rats.

Authors:  Leigh C Walker; Hanna E Kastman; Elena V Krstew; Andrew L Gundlach; Andrew J Lawrence
Journal:  Br J Pharmacol       Date:  2017-08-23       Impact factor: 8.739

Review 8.  Relaxin' the brain: a case for targeting the nucleus incertus network and relaxin-3/RXFP3 system in neuropsychiatric disorders.

Authors:  Jigna Rajesh Kumar; Ramamoorthy Rajkumar; Tharindunee Jayakody; Subhi Marwari; Jia Mei Hong; Sherie Ma; Andrew L Gundlach; Mitchell K P Lai; Gavin S Dawe
Journal:  Br J Pharmacol       Date:  2016-09-06       Impact factor: 8.739

9.  Comparative Distribution of Relaxin-3 Inputs and Calcium-Binding Protein-Positive Neurons in Rat Amygdala.

Authors:  Fabio N Santos; Celia W Pereira; Ana M Sánchez-Pérez; Marcos Otero-García; Sherie Ma; Andrew L Gundlach; Francisco E Olucha-Bordonau
Journal:  Front Neuroanat       Date:  2016-04-07       Impact factor: 3.856

10.  Divergent in vivo activity of non-serotonergic and serotonergic VGluT3-neurones in the median raphe region.

Authors:  Andor Domonkos; Litsa Nikitidou Ledri; Tamás Laszlovszky; Csaba Cserép; Zsolt Borhegyi; Edit Papp; Gábor Nyiri; Tamás F Freund; Viktor Varga
Journal:  J Physiol       Date:  2016-04-28       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.